What’s New

Growing from the success of our last meeting, we are excited to introduce the leading experts across the preclinical community to discuss the key challenges within the 3D tissue industry.

This year, we are bringing more expertise content with 2 streams focusing on:

  1. Drug Discovery and Target Validation
  2. Translational Developments in Disease Modeling

Across 2 days, choose a stream or switch between both with your colleagues to learn even more from our industry experts and enhance the predictive success of your pipeline.

Join us for:

  • Industry cross-talk between FDA, NIH and IQ consortia on how the latest partnerships are driving preclinical 3D guidelines towards scientific advancement.
  • Greater focus the latest validation techniques to enhance reproducibility and increase the therapeutic success of drug candidates.
  • Revealing insight into the latest imaging techniques incorporated into translational studies to improve disease modeling in cardiac, CNS, fibrosis models and many more.

 

See below a selection of organizations showcasing exclusive unpublished data and presentations from:

  • Amgen
  • Biogen
  • Celgene
  • Draper
  • FDA
  • Genentech
  • Merk
  • MIT
  • NIH
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Sanofi
  • Stemonix
  • Takeda
  • Tara Biosciences
  • VIIBRE